BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2045931)

  • 21. In vivo estimates of hepatic binding protein concentration: correlation with classical indicators of hepatic functional reserve.
    Kudo M; Vera DR; Stadalnik RC; Trudeau WL; Ikekubo K; Todo A
    Am J Gastroenterol; 1990 Sep; 85(9):1142-8. PubMed ID: 2389727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The preparation of hepatic receptor imaging agent 99mTc-DTPA-NGA].
    Li Y; Guan C; Wang Q
    Hua Xi Yi Ke Da Xue Xue Bao; 1996 Mar; 27(1):54-8. PubMed ID: 9208621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Automatic preparation of radiopharmacokinetic data for in vivo estimation of receptor biochemistry.
    Xu JC; Vera DR; Stadalnik RC
    J Nucl Med; 1996 Nov; 37(11):1896-902. PubMed ID: 8917199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of (99m)Tc-DMP-NGA as a novel hepatic asialoglycoprotein receptor imaging agent.
    Yang W; Mou T; Zhang X; Wang X
    Appl Radiat Isot; 2010 Jan; 68(1):105-9. PubMed ID: 19815422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinction between hepatic focal nodular hyperplasia and malignant liver lesions using technetium-99m-galactosyl-neoglycoalbumin.
    Kurtaran A; Müller C; Novacek G; Kaserer K; Mentes M; Raderer M; Pidlich J; Eibenberger K; Angelberger P; Virgolini I
    J Nucl Med; 1997 Dec; 38(12):1912-5. PubMed ID: 9430468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vivo measurement of hepatic binding protein in chronic liver disease--validation as a measure of hepatic functional reserve].
    Kudo M; Vera DR; Stadalnik RC; Trudeau WL; Ikekubo K; Todo A
    Nihon Shokakibyo Gakkai Zasshi; 1991 Jan; 88(1):40-50. PubMed ID: 1851238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tc-NGA imaging in liver transplantation: preliminary clinical experience.
    Woodle ES; Ward RE; Stadalnik RC; Vera DR
    Surgery; 1989 Mar; 105(3):401-7. PubMed ID: 2646744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tc-99m galactosyl-neoglycoalbumin hepatic scintigraphy in fulminant hepatic failure.
    Moragas M; Pavía J; Ginés A; Ros D; Solá M; Huguet M; Pons F; Setoain J
    Clin Nucl Med; 1995 Apr; 20(4):329-33. PubMed ID: 7788990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in the intracellular processing of the radiolabel following the uptake of iodine-125- and technetium-99m-neogalactosyl albumin by the isolated perfused rat liver.
    Gore S; Morris AI; Gilmore IT; Maltby PJ; Thornback JR; Billington D
    J Nucl Med; 1991 Mar; 32(3):506-11. PubMed ID: 2005461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium 99m galactosyl human serum albumin.
    Kudo M; Todo A; Ikekubo K; Yamamoto K; Vera DR; Stadalnik RC
    Hepatology; 1993 May; 17(5):814-9. PubMed ID: 8491449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor index via hepatic asialoglycoprotein receptor imaging: correlation with chronic hepatocellular damage.
    Kudo M; Todo A; Ikekubo K; Hino M
    Am J Gastroenterol; 1992 Jul; 87(7):865-70. PubMed ID: 1615940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic performance of a receptor-binding radiopharmacokinetic model.
    Vera DR; Stadalnik RC; Metz CE; Pimstone NR
    J Nucl Med; 1996 Jan; 37(1):160-4. PubMed ID: 8543988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo functional imaging using receptor-binding radiopharmaceuticals. Technetium 99m-galactosyl-neoglycoalbumin as a model.
    Stadalnik RC; Kudo M; Eckelman WC; Vera DR
    Invest Radiol; 1993 Jan; 28(1):64-70. PubMed ID: 8425855
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pharmacokinetic studies on 99mTc-NGA in human].
    Guan C; Chen Q; Tan T
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Sep; 24(3):268-70. PubMed ID: 8288194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic membrane receptors for glycoproteins.
    Steer CJ; Ashwell G
    Prog Liver Dis; 1986; 8():99-123. PubMed ID: 2940622
    [No Abstract]   [Full Text] [Related]  

  • 36. Liver function in acute viral hepatitis as determined by a hepatocyte-specific ligand: 99mTc-galactosyl-neoglycoalbumin.
    Virgolini I; Müller C; Höbart J; Scheithauer W; Angelberger P; Bergmann H; O'Grady J; Sinzinger H
    Hepatology; 1992 Apr; 15(4):593-8. PubMed ID: 1551636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Characterization of receptor-mediated binding of 99mTc-NGA in vitro].
    Guan C; Chen Q; Tan T
    Hua Xi Yi Ke Da Xue Xue Bao; 1994 Mar; 25(1):22-5. PubMed ID: 8070765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Estimation of hepatic functional reserve by asialoglycoprotein receptor-binding, radiolabeled synthetic ligand Tc-99m-galactosyl-neoglycoalbumin--preclinical and clinical studies].
    Kudo M; Todo A; Ikekubo K; Hino M; Ito H; Yamaguchi H; Saiki Y; Yamamoto K; Yonekura Y; Torizuka K
    Kaku Igaku; 1987 Nov; 24(11):1653-62. PubMed ID: 3446908
    [No Abstract]   [Full Text] [Related]  

  • 39. A quantitative model of technetium-99m-DTPA-galactosyl-HSA for the assessment of hepatic blood flow and hepatic binding receptor.
    Ha-Kawa SK; Tanaka Y
    J Nucl Med; 1991 Dec; 32(12):2233-40. PubMed ID: 1744708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local identifiability of a receptor-binding radiopharmacokinetic system having measured parameters of known uncertainty.
    Vera DR; Scheibe PO; Banin Y; Stadalnik RC
    IEEE Trans Biomed Eng; 1994 Sep; 41(9):891-7. PubMed ID: 7959816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.